Li Y, Chen M, Ma Y, Yang Y, Cheng Y, Ma H
NPJ Sci Food. 2022; 6(1):50.
PMID: 36316361
PMC: 9622822.
DOI: 10.1038/s41538-022-00167-x.
Panigrahi M, Kaliaperumal V, Akella A, Venugopal G, Ramadass B
Sci Rep. 2022; 12(1):8450.
PMID: 35589904
PMC: 9120160.
DOI: 10.1038/s41598-022-12431-x.
Kayisoglu O, Schlegel N, Bartfeld S
J Mol Med (Berl). 2021; 99(4):517-530.
PMID: 33538854
PMC: 8026474.
DOI: 10.1007/s00109-021-02043-9.
Wu Q, Li Q, Zhang X, Ntim M, Wu X, Li M
PeerJ. 2020; 8:e10262.
PMID: 33194428
PMC: 7602682.
DOI: 10.7717/peerj.10262.
Steinke I, Ghanei N, Govindarajulu M, Yoo S, Zhong J, Amin R
Front Physiol. 2020; 11:567899.
PMID: 33192565
PMC: 7658318.
DOI: 10.3389/fphys.2020.567899.
Effect of ACTT 8014 on 5-fluorouracil induced intestinal mucositis in Wistar rats.
Ciobanu L, Tefas C, Oancea D, Berce C, Vodnar D, Mester A
Exp Ther Med. 2020; 20(6):209.
PMID: 33149773
PMC: 7604756.
DOI: 10.3892/etm.2020.9339.
New Insights of Oral Colonic Drug Delivery Systems for Inflammatory Bowel Disease Therapy.
Teruel A, Gonzalez-Alvarez I, Bermejo M, Merino V, Marcos M, Sancenon F
Int J Mol Sci. 2020; 21(18).
PMID: 32899548
PMC: 7555849.
DOI: 10.3390/ijms21186502.
Risk of small intestinal bacterial overgrowth in patients receiving proton pump inhibitors proton pump inhibitors plus prokinetics.
Revaiah P, Kochhar R, Rana S, Berry N, Ashat M, Dhaka N
JGH Open. 2018; 2(2):47-53.
PMID: 30483563
PMC: 6206996.
DOI: 10.1002/jgh3.12045.
Biotransformation of extract by rat intestinal microflora: identification and quantification of metabolites using liquid chromatography-tandem mass spectrometry.
Dong W, Zhao J, Zhong F, Zhu W, Jiang J, Wu S
J Ginseng Res. 2017; 41(4):540-547.
PMID: 29021702
PMC: 5628354.
DOI: 10.1016/j.jgr.2016.11.002.
Bacterial Chat: Intestinal Metabolites and Signals in Host-Microbiota-Pathogen Interactions.
Lustri B, Sperandio V, Moreira C
Infect Immun. 2017; 85(12).
PMID: 28947641
PMC: 5695128.
DOI: 10.1128/IAI.00476-17.
Dark Agouti rat model of chemotherapy-induced mucositis: establishment and current state of the art.
Vanhoecke B, Bateman E, Mayo B, Vanlancker E, Stringer A, Thorpe D
Exp Biol Med (Maywood). 2015; 240(6):725-41.
PMID: 25966981
PMC: 4935219.
DOI: 10.1177/1535370215581309.
Compartment-specific immunity in the human gut: properties and functions of dendritic cells in the colon versus the ileum.
Mann E, Bernardo D, English N, Landy J, Al-Hassi H, Peake S
Gut. 2015; 65(2):256-70.
PMID: 25666191
PMC: 4530083.
DOI: 10.1136/gutjnl-2014-307916.
The first 1000 cultured species of the human gastrointestinal microbiota.
Rajilic-Stojanovic M, de Vos W
FEMS Microbiol Rev. 2014; 38(5):996-1047.
PMID: 24861948
PMC: 4262072.
DOI: 10.1111/1574-6976.12075.
Functional and phylogenetic assembly of microbial communities in the human microbiome.
Shafquat A, Joice R, Simmons S, Huttenhower C
Trends Microbiol. 2014; 22(5):261-6.
PMID: 24618403
PMC: 4008634.
DOI: 10.1016/j.tim.2014.01.011.
Evaluation of fecal microorganisms of children with cleft palate before and after palatoplasty.
Vieira N, Borgo H, Dalben G, Bachega M, Pereira P
Braz J Microbiol. 2014; 44(3):835-8.
PMID: 24516450
PMC: 3910197.
DOI: 10.1590/s1517-83822013000300026.
Sex related differences on valproic acid pharmacokinetics after oral single dose.
Ibarra M, Vazquez M, Fagiolino P, Derendorf H
J Pharmacokinet Pharmacodyn. 2013; 40(4):479-86.
PMID: 23784346
DOI: 10.1007/s10928-013-9323-3.
Metabolic activities of ginseng and its constituents, ginsenoside rb1 and rg1, by human intestinal microflora.
Choi J, Hong S, Kim Y, Jang S, Kim N, Joo Han M
J Ginseng Res. 2013; 35(3):301-7.
PMID: 23717073
PMC: 3659535.
DOI: 10.5142/jgr.2011.35.3.301.
Comparative analysis of the gut microbiota in people with different levels of ginsenoside Rb1 degradation to compound K.
Kim K, Jung I, Park S, Ahn Y, Huh C, Kim D
PLoS One. 2013; 8(4):e62409.
PMID: 23638073
PMC: 3639287.
DOI: 10.1371/journal.pone.0062409.
Chitosan as a pore former in coated beads for colon specific drug delivery of 5-ASA.
Omwancha W, Mallipeddi R, Valle B, Neau S
Int J Pharm. 2012; 441(1-2):343-51.
PMID: 23200955
PMC: 3556201.
DOI: 10.1016/j.ijpharm.2012.11.022.
Evaluation of impact of exposure of Sudan azo dyes and their metabolites on human intestinal bacteria.
Pan H, Feng J, He G, Cerniglia C, Chen H
Anaerobe. 2012; 18(4):445-53.
PMID: 22634331
PMC: 5870115.
DOI: 10.1016/j.anaerobe.2012.05.002.